Associated Papers
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma.
Wen Y et al.
Nature Communications, 2024
39572526 (PubMed )
Supplement: 41467_2024_54140_MOESM1_ESM.pdf
K128 ubiquitination constrains RAS activity by expanding its binding interface with GAP proteins.
Magits W et al.
The Embo Journal, 2024
38858602 (PubMed )
Supplement: 44318_2024_146_MOESM2_ESM.pdf
Select a paper to view details